Prothrombin complex concentrate
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
... Factor Xa (FXa) inhibitors are direct oral anticoagulants (DOACs) and safe and effective alternatives to warfarin in preventing stroke in patients with atrial fibrillation and treating venous thrombosis [1]. Apixaban ...
5
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal
... In patients with serious or life threatening bleeding, low dose activated recombinant factor VII provided a more rapid and complete reversal of warfarin anticoagulation as determined by reduction of the INR to a value of ...
7
Safety and efficacy of prothrombin complex concentrate as first line treatment in bleeding after cardiac surgery
... ACC: aortic cross-clamp; ACT: activated clotting time; AF: atrial fibrillation; AKI: acute kidney injury; BMI: body mass index; CABG: coronary artery bypass graft; CI: confidence interval; CPB: cardiopulmonary bypass; ...
9
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital
... a prothrombin complex concentrate (PCC; Beriplex P/N, CSL Behring, Marburg, Germany) to treat severe bleeding in a variety of settings: cardiac surgery, warfarin therapy and other ...
7
Goal directed coagulation management of major trauma patients using thromboelastometry (ROTEM®) guided administration of fibrinogen concentrate and prothrombin complex concentrate
... Fibrinogen concentrate [20,21] and prothrombin complex concentrate (PCC) [22,23] have each previously been administered to trauma and surgical patients with success, albeit not in studies ...
11
Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
... Background: Although factor Xa inhibitors have become a popular choice for chronic oral anticoagulation, effective drug reversal remains difficult due to a lack of specific antidote. Currently, 4-factor ...
6
A review of the clinical utility of INR to monitor and guide administration of prothrombin complex concentrate to orally anticoagulated patients
... of prothrombin complex concentrates (PCC) to OAC ...keywords: prothrombin complex concentrate, reversal of oral anticoagulation and international normalized ratio ...
8
Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
... Two blood products–fresh frozen plasma (FFP) and the new prothrombin complex concentrate (PCC)–are used in addition to vitamin K to reverse warfarin antic- oagulation in emergent situations [3,7-14]. ...
10
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
... four-factor prothrombin complex concentrate, in the management of rivaroxaban-related, life-threatening bleeding is the most recommended/used therapy [8, 9]: In healthy male volunteers, PCC was seen ...
10
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy
... Warfarin and other vitamin K antagonists inhibit the γ -carboxylation of coagulation factors VII, IX, X and II. Vitamin K restores their γ-carboxylation; however, several hours are required before levels assuring normal ...
9
The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor
... Four-factor prothrombin complex concentrate (PCC) is used as an antidote to warfarin, replacing coagulation factors II, VII, IX, and X in their zymogen or inactive ...
8
Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/− fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study
... fibrinogen concentrate only; FC – PCC group: Patients receiving fibrinogen concentrate and prothrombin complex concentrate; FC – PCC – FFP group: Patients receiving fibrinogen ...
10
Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists
... use prothrombin complex concentrate (PCC) for re- versal of factor Xa inhibitors, despite the lack of pro- spective evidence in accordance with current recommendations and guidelines ...[5–7]. ...
9
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial
... or prothrombin complex concentrate administration prior to ...proteins. Prothrombin complex concentrate is a low-volume plasma product that contains both procoagulant and ...
12
Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
... of prothrombin complex concentrate has come into use in critically bleeding pa- ...tients. Prothrombin complex concentrate contains a collection of either three coagulation ...
13
Role of prothrombin complex concentrate in perioperative coagulation therapy
... of prothrombin complex concentrate (PCC) with thera- peutic amounts of vitamin K-dependent factors for the management of bleeding in patients treated with warfarin ...latter, prothrombin, ...
9
Endogenous thrombin potential following hemostatic therapy with 4 factor prothrombin complex concentrate: a 7 day observational study of trauma patients
... Approximately one quarter to one third of all trauma patients present with coagulopathy detectable by standard coagulation tests such as prothrombin time (PT) or acti- vated partial thromboplastin time (aPTT) ...
12
Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
... contains 400 to 960 international units (IU) factor II, 200 to 500 IU factor VII, 400 to 620 IU factor IX and 440 to 1,200 IU factor X. In all cases, the PCC was administered by the physi- cian on duty. The dose of PCC ...
15
An Exploratory Cohort Study Comparing Prothrombin Complex Concentrate and Fresh Frozen Plasma for the Treatment of Coagulopathy After Complex Cardiac Surgery
... Bleeding is a majorcomplication after cardiac surgery using cardiopulmonary bypass (CPB) that exposes patients to the risk of allogeneic blood transfusion and reoperation. Although there are conflicting data, the use of ...
36
Guideline concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)
... 16. Tremey B, Tazarourte K, Ract C, Gabteni M, Lavagna L, Dépret-Vassal J, Segalin V, Saintonge S, Vigué B: Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation-related severe ...
9